New to Meducation?
Sign up
Already signed up? Log In



Harvard Apparatus Regenerative Technology, Connecticut Children’s Medical Center Collaborate to Develop Bioengineered Pediatric Esophageal Solutions

HOLLISTON, Mass., Aug 10, 2015 (BUSINESS WIRE) -- Harvard Apparatus Regenerative Technology, Inc., HART, +5.13% or HART, a biotechnology company developing bioengineered organs for life threatening conditions, has entered into an agreement with Connecticut Children’s Medical Center (Connecticut Children’s) on a pre-clinical collaboration to develop an innovative process for repairing or replacing the esophagus to treat life-threatening pediatric conditions such as esophageal atresia.
over 6 years ago